Transdermal delivery of tadalafil using a novel formulation

References

• Bachhav YG, Patravale VB. (2010). Formulation of meloxicam gel for topical application: in vitro and in vivo evaluation. Acta Pharm 60:153–63
   PubMed Web of Science ®Google Scholar
• Baek JS, Lim JH, Kang JS, et al. (2013). Enhanced transdermal drug delivery of zaltoprofen using a novel formulation. Int J Pharm 453:358–62
   PubMed Web of Science ®Google Scholar
• Bouwstra JA, Honeywell-Nguyen PL. (2002). Skin structure and mode of actions of vehicles. Adv Drug Deliv Rev 54:S41–55
   PubMed Web of Science ®Google Scholar
• Briganti A, Salonia A, Gallina A, et al. (2005). Drug insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction. Nat Clin Pract Urol 2:239–47
   PubMedGoogle Scholar
• Brock GB, McMahon CG, Chen KK, et al. (2002). Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol 168:1332–6
   PubMed Web of Science ®Google Scholar
• Cagno M, Stein PC, Skalko-Basnet N, et al. (2011). Solubilization of ibuprofen with β-cyclodextrin derivatives: energetic and structural studies. J Pharm Biomed Anal 55:446–51
   PubMed Web of Science ®Google Scholar
• Carson C, Shabsigh R, Seqal S, et al. (2005). Trial Evaluating the Activity of Tadalafil for Erectile Dysfunction-United Stated (TREATED-US) Study Group. Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary care academic centers. Urology 65:353–69
   PubMed Web of Science ®Google Scholar
• Chavda HV, Patel CN, Anand IS. (2010). Biopharmaceutics classification system. Syst Rev 1:62–9
   Google Scholar
• Chien YW, Lambert HJ. (1975). Solubilization of steroids by multiple cosolvent systems. Chem Pharm Bull 23:1085–90
   Web of Science ®Google Scholar
• Cho SH, Kim SY, Lee SI, Lee MY. (2006). Hydroxypropyl-β-cyclodetrin inclusion complexes for transdermal delivery: preparation, inclusion properties, stability, and release behavior. J Ind Eng Chem 12:50–9
   Web of Science ®Google Scholar
• Coward RM, Carson CC. (2008). Tadalafil in the treatment of erectile dysfunction. Ther Clin Risk Manaq 4:1315–30
   PubMedGoogle Scholar
• Da Silva ER, de Freitas ZM, Gitirana LDEB, Ricci-Junior E. (2011). Improving the topical delivery of zinc phthalocyanine using oleic acid as a penetration enhancer: in vitro permeation and retention. Drug Dev Ind Pharm 37:569–75
   PubMed Web of Science ®Google Scholar
• De Mello H, Echevarria A, Bernardino AM, et al. (2004). Antileishmanial pyrazolopyridine derivatives: synthesis and structure–activity relationship analysis. J Med Chem 47:5427–32
   PubMed Web of Science ®Google Scholar
• Dos Anjos JLV, Alonso A. (2008). Terpenes increase the portioning and molecular dynamics of an amphipathic spin label in stratum corneum membranes. Int J Pharm 350:103–12
   PubMed Web of Science ®Google Scholar
• El Maghraby GM, Alanazi FK, Alsarra IA. (2009). Transdermal delivery of tadalafil. I. Effect of vehicles on skin permeation. Drug Dev Ind Pharm 35:329–36
   PubMed Web of Science ®Google Scholar
• Farthing CA, Farthing DE, Koka S, et al. (2010). A simple and sensitive HPLC fluorescence method for determination of tadalafil in mouse plasma. J Chromatogr B: Anal Technol Biomed Life Sci 878:2891–5
   PubMed Web of Science ®Google Scholar
• Felton LA, Wiley CJ, Godwin DA. (2002). Influence of hydroxypropyl-beta-cyclodextrin on the transdermal permeation and skin accumulation of oxybenzone. Drug Dev Ind Pharm 28:1117–24
   PubMed Web of Science ®Google Scholar
• Ganeshpurkar A, Vaishya P, Jain S, et al. (2014). Delivery of amphotericin B for effective treatment of candida albicans induced dermal mycosis in rats via emulgel system: formulation and evaluation. Indian J Dermatol 59:369–74
   PubMed Web of Science ®Google Scholar
• Lobenberg R, Amidon GL. (2000). Modern bioavailabilty, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm Biopharm 50:3–12
   PubMed Web of Science ®Google Scholar
• Naik A, Pechtold LARM, Potts RO, Guy RH. (1995). Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans. J Control Release 37:299–306
   Web of Science ®Google Scholar
• Nair MP, Kronfol ZA, Schwartz SA. (1990). Effects of alcohol and nicotine on cytotoxic functions of human lymphocytes. Clin Immunol Immunopathol 54:395–409
   PubMedGoogle Scholar
• Nasongkla N, Wiedmann AF, Bruening A, et al. (2003). Enhancement of solubility and bioavailability of beta-lapachone using cyclodextrin inclusion complexes. Pharm Res 20:1623–33
   Web of Science ®Google Scholar
• Ogiso T, Iwaki M, Paku T. (1995). Effect of various enhancers on transdermal penetration of indomethacin and urea, and relationship between penetration parameters and enhancement factors. J Pharm Sci 84:482–8
   PubMed Web of Science ®Google Scholar
• Ongpipattanakul B, Burnette RR, Potts RO, Francoeur ML. (1991). Evidence that oleic acid exists in a separate phase within stratum corneum lipids. Pharm Res 8:350–4
   PubMed Web of Science ®Google Scholar
• Onishi H, Takahashi M, Machida M. (2005). PLGA implant tablet of ketoprofen: comparison of in vitro and in vivo releases. Biol Pharm Bull 28:2011–15
   PubMed Web of Science ®Google Scholar
• Saharan S, Kohil U, Lodha R, et al. (2009). Thrombotic microangiopathy associated with Plasmodium vivax malaria. Pediatr Nephrol 24:623–4
   PubMed Web of Science ®Google Scholar
• Shinha VR, Kaur MP. (2000). Permeation enhancers for transdermal drug delivery. Drug Dev Ind Pharm 26:1131–40
   PubMed Web of Science ®Google Scholar
• Som I, Bhatia K, Yasir M. (2012). Status of surfactants as penetration enhancers in transdermal drug delivery. J Pharm Bioallied Sci 4:2–9
   PubMedGoogle Scholar
• Takeuchi T, Yasukawa H, Uamaoka Y, et al. (1992). Effects of fatty acids, fatty amines and propylene glycol on rat stratum corneum lipids and proteins in vitro measured by Fourier transform infrared/attenuated total reflection (FT-IR/ATR) spectroscopy. Chem Pharm Bull 40:1887–92
   PubMed Web of Science ®Google Scholar
• Tanojo H, Boelsma E, Junginger HE, et al. (1999). In vivo human skin permeability enhancement by oleic acid: a laser Doppler velocimetry study. J Control Release 58:97–104
   PubMed Web of Science ®Google Scholar
• Touitou E, Godin B, Karl Y, et al. (2002). Oleic acid, a skin penetration enhancer, affects Langerhans cells and corneocytes. J Control Release 80:1–7
   PubMed Web of Science ®Google Scholar
• Verma P, Pathak K. (2010). Therapeutic and cosmeceutical potential of ethosomes: an overview. J Adv Pharm Technol Res 1:274–82
   PubMedGoogle Scholar
• Wonglertnirant N, Ngawhirunpat T, Kumpugdee-Vollrath M. (2012). Evaluation of the mechanism of skin enhancing surfactants on the biomembrane of shed snake skin. Biol Pharm Bull 35:523–31
   PubMed Web of Science ®Google Scholar